top of page
  • Regulatory House

Recommendations of SÚKL for submitters of bioequivalence (BE) studies

Applicants for BE studies often do not include some of the required documents when submitting their application for accelerated study assessment or incorrect payment is made, which subsequently increases the assessment time. For this reason, SÚKL has issued short guidance on its website regarding the documentation requirements for bioequivalence (BE) studies submitted through CTIS together with payment information so that the study can be successfully validated and subsequently assessed under the accelerated regime.  In the link you will find both a list of these documents, but also information on the amount of the payment and the payment method, so that the assessment is not delayed in the validation phase by the completion of comments.

5 views0 comments

Recent Posts

See All

Which products cannot be registered?

SÚKL has published several types of products on its website for which it is no longer possible to apply for registration as a medicinal product, as they do not meet the definition under Section 2 of A

New general MDCG guideline Medical Device Software (MDSW)

The MDCG 2023-4 provides several examples to help determine whether or not the hardware and the software used with it can be considered medical devices. It does not focus on clinical evaluation or cyb


bottom of page